Antihemostatic Therapy and Endoscopic Biliary Sphincterotomy Induced Bleeding

Yuksek Ihtisas Hospital

Status: Unknown

Conditions: Endoscopic Biliary Sphincterotomy; Bleeding

Study type: Observational

Funder types: Other

Identifiers

NCT01098617

PMS207

Details and patient eligibility

About

The aim of the study is to observe the effects of antihemostatic therapy including nonsteroidal antiinflammatory, anticoagulant and antiaggregant therapy and other patient and procedure related factors on the risk of endoscopic biliary sphincterotomy induced bleeding.

Enrollment: 350 estimated patients

Sex: All

Ages: 17+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hospitalization
• Endoscopic sphincterotomy
• The patients whose warfarin treatment was stopped and INR was normalized prior to examination

Exclusion criteria

• The patients who had undergone endoscopic cholangiography with no sphincterotomy
• Outpatient procedures

Trial design

350 participants in 1 patient group

hemorrhage

Description:

The patients who had bleeding induced by endoscopic sphincterotomy